The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
Journal of the American College of Cardiology 2009 Oct 54 (17): 1609-16.
Voora Deepak, Shah Svati H, Spasojevic Ivan, Ali Shazia, Reed Carol R, Salisbury Benjamin A, Ginsburg Geoffrey
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
Pharmacological research 2007 Apr 55 (4): 310-7.
Zuccaro Piergiorgio, Mombelli Giuliana, Calabresi Laura, Baldassarre Damiano, Palmi Ilaria, Sirtori Cesare